PRVA 股价在指引上调后创下 52 周新高;第二季度节拍(纳斯达克股票代码:PRVA)


以季度业绩为标题的滚动报纸

Zerbor/iStock via Getty Images

Privia Health (NASDAQ:PRVA), a provider of value-based care, reported better than expected financials for Q2 2022 and raised its full-year outlook sending its shares a 52-week in the morning hours Thursday.

Privia’s (PRVA) revenue for the quarter jumped ~49% YoY to $335.5M as practice collections improved ~67% YoY to $615.5M while value-based care attributed lives gained ~16% YoY ~856K.

As care margin improved ~36% YoY to $76.2M, the net loss for the quarter narrowed to $10.5M from $172.5M in the prior-year quarter when the company recorded $202.6M of non-cash or non-recurring expenses.

Revenue for the first half of the year ~48% YoY to $649.3M, driven by a ~66% YoY growth in practice collections that generated $~$1.2B.

与此同时,现金及等价物较 2021 年底下降约 9% 至 2.922 亿美元,本季度未偿债务已全部偿还。

为反映上半年的强劲表现和持续的业务发展势头,Privia (PRVA )上调了全年展望,将 2022 年的收入预测设定为先前观点的高端。

该公司预计 2022 年的收入约为 $1.23B – $1.30,最初符合当前的共识。

Source: https://seekingalpha.com/news/3871711-prva-stock-hits-52-week-high-after-guidance-raise-q2-beat